Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.920
-0.120 (-5.88%)
At close: Apr 1, 2025, 4:00 PM
2.080
+0.160 (8.33%)
After-hours: Apr 1, 2025, 7:03 PM EDT

Aprea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
11181818--
Market Cap Growth
1.81%1.81%0.11%---
Enterprise Value
-12-7-6-12--
Last Close Price
2.043.294.706.62--
PS Ratio
7.4811.9030.11---
PB Ratio
0.580.870.960.65--
P/TBV Ratio
0.930.931.040.68--
Debt / Equity Ratio
----0.00-
Asset Turnover
0.060.060.02---
Quick Ratio
6.806.804.938.997.25-
Current Ratio
7.027.025.149.427.73-
Return on Equity (ROE)
-66.66%-66.66%-63.19%-294.69%--
Return on Assets (ROA)
-38.39%-38.39%-36.62%-53.71%--
Return on Capital (ROIC)
-46.03%-46.03%-42.77%-60.94%--
Earnings Yield
-119.78%-72.47%-81.35%-642.23%--
FCF Yield
-125.45%-75.90%-69.87%-142.58%--
Buyback Yield / Dilution
-52.31%-52.31%-118.31%-55.69%-0.72%-
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q